ImpediMed Releases Heart Failure and Renal Disease Software
Filed with ASX · · 2 pages · English
Watch Impedimed's latest callImpedimed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of Impedimed (ASX:IPD) Q1 2027 Earnings CallEarlier from Impedimed
- Successful Completion of $10m Institutional Portion of Offer
- Prospectus
- ImpediMed Secures Order from Large US Oncology Care Network
- New National Purchasing Agreement for Lymphoedema Prevention
- Baylor Scott & White Expands SOZO Use with New iOS Software
Later from Impedimed
- Appendix 4C - Quarter ended 31 March 2020
- Change in substantial holding
- Independent BIS RE-AIM Analysis to be Released at ASCO 2020
- NSW Health Expands SOZO Use for Lymphoedema Prevention
- Completion of Retail Entitlement Offer
Follow Impedimed into a list and get an email when it puts out news.
Follow Impedimed